In a registry-based cohort study of 109 institutions, Mayo Clinic researchers evaluated the use of corticosteroids in hospitalized patients needing oxygen due to severe COVID-19 disease. The study assessed biomarker-concordant corticosteroid use in patients tested for a protein that causes inflammation.
Leave A Comment